Physician profile
Casey L Smith
NPI 1467614396
$5,165.67
in general payments reported to CMS, 2019-2025
23 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,583 · 2020: $113 · 2021: $143 · 2022: $2,148 · 2023: $498 · 2024: $304 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,904.11 | 2022 | |
| Nuvasive, INC. | $1,502.92 | 2019 | |
| Stryker Corporation | $407.79 | 2019-2023 | Sonopet Iq, Core, Actishield Cf |
| Depuy Synthes Sales INC. | $360.59 | 2019-2023 | Expedium |
| Pylant Medical | $208.86 | 2024-2025 | |
| Kuros Biosciences USA, INC | $187.76 | 2025 | Magnetos |
| Bioventus LLC | $116.42 | 2020-2024 | Bonescalpel & Sonicone (O.R.) |
| Pacira Therapeutics, INC. | $86.98 | 2021 | |
| Baxter Healthcare | $70.05 | 2024-2025 | Floseal, Tisseel |
| Innovation Technologies INC | $37.08 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $33.17 | 2022 | |
| Ethicon US, LLC | $33.09 | 2024 | Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Convatec INC. | $26.25 | 2023 | |
| Becton, Dickinson and Company | $25.08 | 2022 | |
| Biocomposites INC | $24.93 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $21.65 | 2025 | |
| Smith+Nephew, INC. | $21.28 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $18.52 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.01 | 2022 | |
| Novo Nordisk INC | $16.47 | 2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $15.94 | 2023 | Mounjaro, Trulicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.72 | 2022 | |
| Pfizer INC. | $14.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.